Literature DB >> 33707493

An ex vivo model of medical device-mediated bacterial skin translocation.

Hao Wang1, Anant Agrawal2, Yi Wang1, David W Crawford3, Zachary D Siler3, Marnie L Peterson3, Ricky T Woofter4, Mohamed Labib5, Hainsworth Y Shin1, Andrew P Baumann6, K Scott Phillips7.   

Abstract

The skin is a barrier and part of the immune system that protects us from harmful bacteria. Because indwelling medical devices break this barrier, they greatly increase the risk of infection by microbial pathogens. To study how these infections can be prevented through improved clinical practices and medical device technology, it is important to have preclinical models that replicate the early stages of microbial contamination, ingress, and colonization leading up to infection. At present, there are no preclinical ex vivo models specifically developed to simulate conditions for indwelling medical devices. Translocation of pathogens from outside the body across broken skin to normally sterile internal compartments is a rate-limiting step in infectious pathogenesis. In this work, we report a sensitive and reproducible ex vivo porcine skin-catheter model to test how long antimicrobial interventions can delay translocation. Skin preparation was first optimized to minimize tissue damage. The presence of skin dramatically decreased bacterial migration time across the polyurethane catheter interface from > 96 h to 12 h. Using visual colony detection, fluorescence, a luminescent in vitro imaging system, and confocal microscopy, the model was used to quantify time-dependent differences in translocation for eluting and non-eluting antimicrobial catheters. The results show the importance of including tissue in preclinical biofilm models and help to explain current gaps between in vitro testing and clinical outcomes for antimicrobial devices.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33707493      PMCID: PMC7952406          DOI: 10.1038/s41598-021-84826-1

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  45 in total

Review 1.  Mechanisms of biofilm resistance to antimicrobial agents.

Authors:  T F Mah; G A O'Toole
Journal:  Trends Microbiol       Date:  2001-01       Impact factor: 17.079

2.  The migration of Proteus mirabilis and other urinary tract pathogens over Foley catheters.

Authors:  N Sabbuba; G Hughes; D J Stickler
Journal:  BJU Int       Date:  2002-01       Impact factor: 5.588

3.  Safety of Osseointegrated Implants for Transfemoral Amputees: A Two-Center Prospective Cohort Study.

Authors:  Munjed Al Muderis; Aditya Khemka; Sarah J Lord; Henk Van de Meent; Jan Paul M Frölke
Journal:  J Bone Joint Surg Am       Date:  2016-06-01       Impact factor: 5.284

4.  Unusual "flesh-eating" strain of Escherichia coli.

Authors:  David Grimaldi; Stéphane Bonacorsi; Hélène Roussel; Benjamin Zuber; Hélène Poupet; Jean-Daniel Chiche; Claire Poyart; Jean-Paul Mira
Journal:  J Clin Microbiol       Date:  2010-08-04       Impact factor: 5.948

Review 5.  In vitro methods for the evaluation of antimicrobial surface designs.

Authors:  Jelmer Sjollema; Sebastian A J Zaat; Veronique Fontaine; Madeleine Ramstedt; Reto Luginbuehl; Karin Thevissen; Jiuyi Li; Henny C van der Mei; Henk J Busscher
Journal:  Acta Biomater       Date:  2018-02-10       Impact factor: 8.947

6.  Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group.

Authors:  I Raad; R Darouiche; J Dupuis; D Abi-Said; A Gabrielli; R Hachem; M Wall; R Harris; J Jones; A Buzaid; C Robertson; S Shenaq; P Curling; T Burke; C Ericsson
Journal:  Ann Intern Med       Date:  1997-08-15       Impact factor: 25.391

7.  The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin.

Authors:  I Raad; R Darouiche; R Hachem; M Mansouri; G P Bodey
Journal:  J Infect Dis       Date:  1996-02       Impact factor: 5.226

8.  Development, standardization and testing of a bacterial wound infection model based on ex vivo human skin.

Authors:  Christoph Schaudinn; Christin Dittmann; Jana Jurisch; Michael Laue; Nazende Günday-Türeli; Ulrike Blume-Peytavi; Annika Vogt; Fiorenza Rancan
Journal:  PLoS One       Date:  2017-11-15       Impact factor: 3.240

9.  Removal of Staphylococcus aureus from skin using a combination antibiofilm approach.

Authors:  Yi Wang; Xiaojuan Tan; Chuanwu Xi; K Scott Phillips
Journal:  NPJ Biofilms Microbiomes       Date:  2018-08-06       Impact factor: 7.290

Review 10.  Human lung ex vivo infection models.

Authors:  Andreas C Hocke; Norbert Suttorp; Stefan Hippenstiel
Journal:  Cell Tissue Res       Date:  2016-12-20       Impact factor: 5.249

View more
  1 in total

Review 1.  Targeting Persistent Biofilm Infections: Reconsidering the Topography of the Infection Site during Model Selection.

Authors:  Ilana Kolodkin-Gal; Malena Cohen-Cymberknoh; Gideon Zamir; Igor Tsesis; Eyal Rosen
Journal:  Microorganisms       Date:  2022-06-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.